- Non-pathogenic, non-replicative, immune protected bacteria engineered to safely deliver biologic therapeutic payloads intracellular to targeted tissues
- Bacteria capable of delivering biologics as in mRNA, siRNA, proteins/nanobodies, and CRISPR/Cas, independent of size
- Reaches tissues that cannot be targeted by viral vectors or lipid nanoparticles
- Efficiently target even hard-to-reach tissues and tumors
- Revolutionizes future of treatment by ensuring better outcomes for patients
